Solifenacin for the treatment of overactive bladder

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.6, 2011-11, pp. : 691-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity

By Wyndaele Jean-Jacques

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 485-494

Future Medicine

Access to resources Recommend Favorite

Combination of solifenacin and mirabegron for overactive bladder management

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 498-499

John Wiley & Sons Inc

Access to resources Recommend Favorite

Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes

By Mallett Veronica Burks David Garely Alan D. Smith Neila

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 821-831

Informa Healthcare

Access to resources Recommend Favorite

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

By Speakman Mark Khullar Vik Mundy Anthony Odeyemi Isaac Bolodeoku John

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2173-2179

Informa Healthcare

Access to resources Recommend Favorite

The cost-effectiveness of solifenacin vs. trospium in the treatment of patients with overactive bladder in the German National Health Service

By Nazir J. Hart W.M.

Journal of Medical Economics, Vol. 17, Iss. 6, 2014-06 ,pp. : 408-414

Informa Healthcare

Access to resources Recommend Favorite